News | February 09, 2026
HCG reports robust Q3 & 9M FY26 growth, strengthening its lead in Indian oncology
HCG clinicians contributing to one of the largest bodies of oncology research from India
HCG clinicians contributing to one of the largest bodies of oncology research from India
US revenue increased 43% to $12.9 billion, fueled by a 50% jump in volume, partially offset by a 7% decline in realized prices
BioNTech is positioning 2026 as a defining year in its transition toward a multi-product oncology company
After leading AstraZeneca's Oncology areas nationally and internationally, Laura Colón will assume the presidency of AstraZeneca in one of its priority global markets
Coverage has been significantly strengthened across key therapeutic categories, including anti-tubercular, anti-diabetic and anti-cancer medicines, as well as iron supplements, thereby ensuring more comprehensive standardisation of medicines used under various National Health Programmes
The new powder formulation gives children and adults living with Rett syndrome greater flexibility and choice in dose volume and taste
Vamikibart is the first targeted, non-steroid treatment designed to address the underlying inflammation driving UME
Liraglutide Injection, 18 mg/3 mL (6 mg/mL) Single-Patient-Use Prefilled Pen is bioequivalent to Victoza Injection, 18 mg/3 mL (6 mg/mL) of Novo Nordisk
Wegovy achieved significant weight loss with one in three study participants losing 20% or more body weight
Subscribe To Our Newsletter & Stay Updated
